Dodge & Cox 13F: Cuts Haleon (HLN) Stake by $47M
Dodge & Cox reduced its stake in Haleon, selling over 5.2 million shares.
Reviewed by automated data checks against the source filing. How we make and check alerts
Dodge & Cox sold 5,215,789 shares from its stake in Haleon plc ($HLN), a 3.44% decrease, according to a 13F filing with the SEC dated May 14, 2026. It reported 146,539,663 shares worth $1.32 billion at the end of the quarter.
Since the filing, $HLN is up 4.6% after 1 week, up 1.8% after 1 month and up 14.5% to date (from the $8.85 close on May 14, 2026).
HLN
Haleon plc
Key Points
- Dodge & Cox reduced its stake in Haleon by 3.4%, cutting 5.2 million shares to hold 146.5 million shares.
- Dodge & Cox held 146,539,663 $HLN shares at quarter end, down 3.44% from the prior quarter.
- Haleon's stock trades near $9.03 with a market cap of $40.24 billion and a P/E ratio of 18.6.
- Haleon offers a 2.14% dividend yield, with a payout ratio of 37.08%.
Get $HLN trade alerts by text
We text you when insiders, Congress or big funds trade $HLN. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Haleon plc alert may contain errors. Disclosures
Dodge & Cox has trimmed its position in Haleon (NYSE:HLN) by 3.4%, according to its latest 13F filing with the SEC. The fund sold 5,215,789 shares, bringing its total holdings to 146,539,663 shares valued at approximately $1.32 billion as of the reporting period.
What Changed in Dodge & Cox's Haleon Position
Dodge & Cox cut its stake in Haleon, reducing its holdings from 151,755,452 shares to 146,539,663 shares, a decrease of 5,215,789 shares. This move represents a 3.4% reduction in its position. The reported value of these holdings is around $1.32 billion.
Haleon plc Stock Down 2.7%
Shares of NYSE:HLN traded near $9.03 recently. Haleon, with a market cap of about $40.24 billion, has a P/E ratio of 18.6 and a forward P/E of 14.9. The stock's beta is relatively low at 0.246, indicating less volatility compared to the broader market. It has a 52-week range from $8.65 to $11.28, with a 50-day moving average of $9.34 and a 200-day moving average of $9.73. The company's current ratio is 0.922, and its quick ratio is 0.677, alongside a debt-to-equity ratio of 52.372.
Recent Earnings
Haleon reported revenue of $11.03 billion, reflecting a modest growth of 0.6%. The company achieved a net margin of 15.11% and a return on equity of 10.27%. Earnings per share stood at $0.49. Haleon's next earnings announcement is scheduled for February 25, 2026.
Dividend
Haleon offers a dividend rate of $0.19 per share, yielding 2.14%. The dividend payout ratio is 37.08%, providing a steady income stream for investors.
About Haleon
Haleon plc, headquartered in Weybridge, United Kingdom, is a key player in the healthcare sector, specifically in drug manufacturing. The company develops and sells a variety of consumer healthcare products across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. Its well-known brands include Sensodyne, Polident, Centrum, and Advil. Led by CEO Brian James McNamara, Haleon employs around 24,535 people.
Bottom Line
Dodge & Cox's decision to trim its stake in Haleon is a notable move in the fund's portfolio management strategy. Investors keep a close watch on such filings to gauge fund managers' confidence in a stock. It's important to remember that 13F filings are backward-looking, reflecting positions at the end of the reporting period and may not indicate current holdings.
Related Filing Alerts
Source: Dodge & Cox's 13F filing on $HLN (May 14, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Find the original filing: Dodge & Cox 13F filings on SEC EDGAR. Written by software, not financial advice. How we make alerts